Меню
Идёт набор NCT07002450

Left Atrial Imaging Prior to Cardioversion: Leveraging Computed Tomography to Rule Out Thrombus in The Emergency Department (LA CLOTTED)

Без фазы С лечением Atrial Fibrillation (AF) Atrial Flutter

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают
В протоколе указаны: Cardiac computed tomography angiography, Standard of care management.
Кому может быть актуально
Состояния в реестре: Atrial Fibrillation (AF), Atrial Flutter. Базовые параметры: от 18 лет · Все.
Что важно проверить
Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится
США, Канада
Следующий шаг
Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →

Обзор

The goal of this randomized clinical trial is to learn whether patients with symptomatic atrial fibrillation or atrial flutter (AF) who require heart imaging to rule out a blood clot before cardioversion would benefit from cardiac computed tomography angiography (CCT) in the emergency department (ED) compared to current standard of care management. This will be a multicenter trial evaluating whether CCT-facilitated cardioversion in the ED reduces hospital admission, reduces repeat presentations to hospital and improves patient quality of life compared to the current standard of care. Participants will undergo CCT-facilitated cardioversion or be treated according to current standard of care while in the ED and complete quality of life questionnaires in the ED and follow-up at 30 days.

Подробное описание

Atrial fibrillation and atrial flutter (AF) are the most common cardiac arrhythmias worldwide resulting in frequent visits to the emergency department (ED). Some patients can undergo chemical or electrical cardioversion to restore their heart back to a sinus rhythm. However, if a patient is not on blood thinners and the duration of AF is prolonged then blood clots may form in the heart increasing the risk of stroke after cardioversion. Therefore, some patients must undergo heart imaging to rule out any blood clots before cardioversion is considered safe. Transesophageal echocardiography (TEE) is commonly used to rule out blood clots, but it is not readily available in all EDs often resulting in hospital admission to facilitate this test or deferring cardioversion until 3 weeks of blood thinners have been completed.

Cardiac computed tomography angiography (CCT) is a more readily available alternative to TEE that can be done rapidly in the ED. CCT has excellent sensitivity and specificity compared to TEE for identifying cardiac thrombus. If there is no thrombus detected on the CCT then patients could be immediately cardioverted to sinus rhythm thus avoiding an unnecessary hospital admission and reducing the symptom burden associated with remaining in AF.

This study is a multicenter randomized trial that will evaluate the effectiveness of using CCT facilitated cardioversion in the ED compared to current standard of care management.

Вмешательства

  • Диагностический тест Cardiac computed tomography angiography
    Patients will undergo CCT according to the following protocol. A non-contrast enhanced prospective ECG-triggered image will be acquired followed by a contrast-enhanced prospective ECG-triggered image using a tri-phasic contrast protocol. Delayed CT images 60 seconds after the initial contrast-enhanced CT scan will be obtained. Cardiac CT image interpretation will be performed according to routine clinical practices in a pragmatic fashion. The LA will be assessed for filling defects and character
  • Другое Standard of care management
    Patients in the standard of care arm may undergo any combination of the following management strategies in the emergency department (ED) at the discretion of their treating physician: 1\. Transesophageal echocardiogram (TEE) facilitated cardioversion; 2. Rate control; 3. Consultation with inpatient cardiac specialist for assessment/management and consideration of hospital admission; 4. cardioversion after 3 weeks of anticoagulation; and/or 5. Outpatient referral to cardiac specialist or general

Первичные конечные точки

  • Primary composite outcome [Срок оценки: Randomization to 30 days]
Вторичные конечные точки (12)
  • Composite objective outcomes [Срок оценки: Randomization to 30 days]
  • All-cause death [Срок оценки: Randomization to 30 days]
  • Cardiovascular death [Срок оценки: Randomization to 30 days]
  • Stroke, transient ischemic attack, or systemic embolism [Срок оценки: Randomization to 30 days]
  • Hospital admission for a cardiac or AF related reason [Срок оценки: Randomization to 30 days]
  • Repeat presentation to the emergency department [Срок оценки: Randomization to 30 days]
  • AFEQT quality of life [Срок оценки: Randomization to 30 days]
  • SF-36 quality of life [Срок оценки: Randomization to 30 days]
  • Bleeding [Срок оценки: Randomization to 30 days]
  • Admission to hospital for acute kidney injury [Срок оценки: Randomization to 30 days]
  • Length of stay in the emergency department [Срок оценки: From time of arrival until time of discharge or admission (approximately 3 hours)]
  • Normal sinus rhythm [Срок оценки: Randomization to 30 days]

Критерии участия

Критерии включения

  • Age ≥18 years old; and
  • Primary symptomatic AF without a reversible underlying cause (e.g. sepsis, pneumonia, pulmonary embolism, hyperthyroidism)
  • LA imaging required before cardioversion according to local clinical practice guidelines

Критерии исключения

  • Patients with an indication for emergency cardioversion (e.g. hemodynamic instability (systolic blood pressure<90mmHg or signs of shock), cardiac ischemia (ongoing severe chest pain or marked ST depression on ECG >2mm), or pulmonary edema (significant dyspnea, crackles, or hypoxia)); or
  • Contraindication to CCT (renal insufficiency (eGFR< 45ml/min/1.73m2), allergy to intravenous contrast agents, pregnancy (contraindications to radiation exposure), or inability to perform 20-second breath-hold)

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Нет

Дизайн исследования

Распределение
Рандомизированное
Модель
Параллельные группы
Маскирование
Простое слепое
Основная цель
Диагностика

Центры проведения

Канада · 2 центра
  • The Ottawa Hospital Civic Campus — Ottawa
  • Sunnybrook Health Sciences Centre — Toronto
США · 1 центр
  • Penn State Health Milton S. Hershey Medical Center — Hershey

Идентификаторы

NCT: NCT07002450 · 20240752-01T

Первоисточники (государственные реестры)

Открыть это исследование на ClinicalTrials.gov ↗